lys006
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2018 (NCT03497897)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Leukotriene A-4 hydrolaseINHIBITOR
LTA4H inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04147195 | Phase 2 | Jan 20, 2020 | Novartis |
| NCT04074590 | Phase 2 | Nov 14, 2019 | Novartis |
| NCT03827798 | Phase 2 | Feb 27, 2019 | Novartis |
| NCT03497897 | Phase 2 | Aug 31, 2018 | Novartis |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 4 | 4 | 1 | 2018 |
1 organizations
Page 1 / 1